Related references
Note: Only part of the references are listed.Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapy
Susan O'Brien et al.
BLOOD (2008)
Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia
Neil E. Kay et al.
BLOOD (2007)
Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia
N Lamanna et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Complete response in a patient with adult T-cell leukemia (ATL) treated with combination of alemtuzumab and pentostatin
F Ravandi et al.
LEUKEMIA RESEARCH (2006)
A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas
G Enblad et al.
BLOOD (2004)
Phase II study of pentostatin in advanced T-cell lymphoid malignancies - Update of an M D Anderson Cancer Center series
AM Tsimberidou et al.
CANCER (2004)
Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation
T Kaiser et al.
BLOOD (2004)
A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories
M Herling et al.
BLOOD (2004)
Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome:: report on a series of 21 patients
K Belhadj et al.
BLOOD (2003)
Peripheral T-cell lymphomas: diagnosis and management
CE Dearden et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2003)
Phase 2 study of alemtuzumab (anti-CD52 monoclonal antibody) in patients with advanced mycosis fungoides/Sezary syndrome
J Lundin et al.
BLOOD (2003)
Pentostatin and cyclophosphamide: An effective new regimen in previously treated patients with chronic lymphocytic leukemia
MA Weiss et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109)
K Tsukasaki et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2003)
High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H
CE Dearden et al.
BLOOD (2001)
Hepatosplenic gamma/delta T-cell lymphoma in bone marrow - A sinusoidal neoplasm with blastic cytologic features
F Vega et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2001)
Share Paper
